Does the media refer more to BAX or AMN?

In the previous week, AMN Healthcare Services had 7 more articles in the media than Baxter International. MarketBeat recorded 9 mentions for AMN Healthcare Services and 2 mentions for Baxter International. Baxter International's average media sentiment score of 0.59 beat AMN Healthcare Services' score of 0.29 indicating that Baxter International is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Baxter International 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AMN Healthcare Services 1 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to DVA or BAX?

In the previous week, DaVita had 7 more articles in the media than Baxter International. MarketBeat recorded 9 mentions for DaVita and 2 mentions for Baxter International. DaVita's average media sentiment score of 0.92 beat Baxter International's score of 0.59 indicating that DaVita is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DaVita 5 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Baxter International 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor DXCM or BAX?

In the previous week, DexCom had 22 more articles in the media than Baxter International. MarketBeat recorded 24 mentions for DexCom and 2 mentions for Baxter International. DexCom's average media sentiment score of 1.13 beat Baxter International's score of 0.59 indicating that DexCom is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DexCom 16 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Baxter International 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor RMD or BAX?

In the previous week, ResMed had 8 more articles in the media than Baxter International. MarketBeat recorded 10 mentions for ResMed and 2 mentions for Baxter International. ResMed's average media sentiment score of 1.38 beat Baxter International's score of 0.59 indicating that ResMed is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ResMed 9 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Baxter International 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Baxter International (BAX) Competitors

$22.04 0.00 (0.00%)

Closing price 06/26/2026 03:59 PM Eastern

Extended Trading

$21.98 -0.06 (-0.29%)

As of 06/26/2026 07:50 PM Eastern

Compare

BAX vs. AMN, DVA, BDX, DXCM, and RMD

Should you buy Baxter International stock or one of its competitors? MarketBeat compares Baxter International with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Baxter International include AMN Healthcare Services (AMN), DaVita (DVA), Becton, Dickinson and Company (BDX), DexCom (DXCM), and ResMed (RMD). These companies are all part of the "medical" sector.

How does Baxter International compare to AMN Healthcare Services?

Baxter International (NYSE:BAX) and AMN Healthcare Services (NYSE:AMN) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability.

AMN Healthcare Services has lower revenue, but higher earnings than Baxter International. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Baxter International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baxter International	$11.24B	1.01	-$957M	-$2.13	N/A
AMN Healthcare Services	$2.73B	0.46	-$95.70M	-$0.87	N/A

AMN Healthcare Services has a net margin of -0.95% compared to Baxter International's net margin of -9.70%. AMN Healthcare Services' return on equity of 18.01% beat Baxter International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Baxter International	-9.70%	16.15%	5.24%
AMN Healthcare Services	-0.95%	18.01%	5.19%

Baxter International has a beta of 0.64, meaning that its stock price is 36% less volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.44, meaning that its stock price is 56% less volatile than the broader market.

90.2% of Baxter International shares are held by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are held by institutional investors. 0.2% of Baxter International shares are held by insiders. Comparatively, 1.1% of AMN Healthcare Services shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Baxter International currently has a consensus price target of $19.73, suggesting a potential downside of 10.49%. AMN Healthcare Services has a consensus price target of $27.00, suggesting a potential downside of 17.19%. Given Baxter International's higher possible upside, analysts plainly believe Baxter International is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baxter International	3 Sell rating(s)	8 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.92
AMN Healthcare Services	2 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.22

In the previous week, AMN Healthcare Services had 7 more articles in the media than Baxter International. MarketBeat recorded 9 mentions for AMN Healthcare Services and 2 mentions for Baxter International. Baxter International's average media sentiment score of 0.59 beat AMN Healthcare Services' score of 0.29 indicating that Baxter International is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Baxter International	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AMN Healthcare Services	1 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

AMN Healthcare Services beats Baxter International on 9 of the 16 factors compared between the two stocks.

How does Baxter International compare to DaVita?

DaVita (NYSE:DVA) and Baxter International (NYSE:BAX) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, risk, institutional ownership, analyst recommendations, dividends, valuation, earnings and profitability.

90.1% of DaVita shares are held by institutional investors. Comparatively, 90.2% of Baxter International shares are held by institutional investors. 1.5% of DaVita shares are held by company insiders. Comparatively, 0.2% of Baxter International shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, DaVita had 7 more articles in the media than Baxter International. MarketBeat recorded 9 mentions for DaVita and 2 mentions for Baxter International. DaVita's average media sentiment score of 0.92 beat Baxter International's score of 0.59 indicating that DaVita is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DaVita	5 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Baxter International	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

DaVita has higher revenue and earnings than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than DaVita, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DaVita	$13.64B	1.02	$746.80M	$10.78	20.11
Baxter International	$11.24B	1.01	-$957M	-$2.13	N/A

DaVita has a net margin of 5.65% compared to Baxter International's net margin of -9.70%. Baxter International's return on equity of 16.15% beat DaVita's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DaVita	5.65%	-270.37%	4.87%
Baxter International	-9.70%	16.15%	5.24%

DaVita has a beta of 0.91, indicating that its stock price is 9% less volatile than the broader market. Comparatively, Baxter International has a beta of 0.64, indicating that its stock price is 36% less volatile than the broader market.

DaVita currently has a consensus price target of $199.17, suggesting a potential downside of 8.14%. Baxter International has a consensus price target of $19.73, suggesting a potential downside of 10.49%. Given DaVita's stronger consensus rating and higher possible upside, analysts plainly believe DaVita is more favorable than Baxter International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DaVita	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.38
Baxter International	3 Sell rating(s)	8 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.92

Summary

DaVita beats Baxter International on 13 of the 16 factors compared between the two stocks.

How does Baxter International compare to Becton, Dickinson and Company?

Baxter International (NYSE:BAX) and Becton, Dickinson and Company (NYSE:BDX) are both large-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, institutional ownership, dividends, analyst recommendations, valuation and risk.

Becton, Dickinson and Company has a net margin of 5.33% compared to Baxter International's net margin of -9.70%. Baxter International's return on equity of 16.15% beat Becton, Dickinson and Company's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Baxter International	-9.70%	16.15%	5.24%
Becton, Dickinson and Company	5.33%	15.37%	7.11%

Baxter International pays an annual dividend of $0.04 per share and has a dividend yield of 0.2%. Becton, Dickinson and Company pays an annual dividend of $4.20 per share and has a dividend yield of 2.7%. Baxter International pays out -1.9% of its earnings in the form of a dividend. Becton, Dickinson and Company pays out 106.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Becton, Dickinson and Company has raised its dividend for 53 consecutive years. Becton, Dickinson and Company is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Baxter International presently has a consensus price target of $19.73, indicating a potential downside of 10.49%. Becton, Dickinson and Company has a consensus price target of $181.00, indicating a potential upside of 15.98%. Given Becton, Dickinson and Company's stronger consensus rating and higher possible upside, analysts plainly believe Becton, Dickinson and Company is more favorable than Baxter International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baxter International	3 Sell rating(s)	8 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.92
Becton, Dickinson and Company	1 Sell rating(s)	8 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.38

Baxter International has a beta of 0.64, meaning that its stock price is 36% less volatile than the broader market. Comparatively, Becton, Dickinson and Company has a beta of 0.22, meaning that its stock price is 78% less volatile than the broader market.

In the previous week, Becton, Dickinson and Company had 13 more articles in the media than Baxter International. MarketBeat recorded 15 mentions for Becton, Dickinson and Company and 2 mentions for Baxter International. Becton, Dickinson and Company's average media sentiment score of 1.15 beat Baxter International's score of 0.59 indicating that Becton, Dickinson and Company is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Baxter International	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Becton, Dickinson and Company	10 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

90.2% of Baxter International shares are owned by institutional investors. Comparatively, 87.0% of Becton, Dickinson and Company shares are owned by institutional investors. 0.2% of Baxter International shares are owned by insiders. Comparatively, 0.4% of Becton, Dickinson and Company shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Becton, Dickinson and Company has higher revenue and earnings than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baxter International	$11.24B	1.01	-$957M	-$2.13	N/A
Becton, Dickinson and Company	$21.84B	1.97	$1.68B	$3.95	39.51

Summary

Becton, Dickinson and Company beats Baxter International on 15 of the 19 factors compared between the two stocks.

How does Baxter International compare to DexCom?

DexCom (NASDAQ:DXCM) and Baxter International (NYSE:BAX) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, media sentiment, dividends and analyst recommendations.

In the previous week, DexCom had 22 more articles in the media than Baxter International. MarketBeat recorded 24 mentions for DexCom and 2 mentions for Baxter International. DexCom's average media sentiment score of 1.13 beat Baxter International's score of 0.59 indicating that DexCom is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DexCom	16 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Baxter International	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

97.8% of DexCom shares are owned by institutional investors. Comparatively, 90.2% of Baxter International shares are owned by institutional investors. 0.3% of DexCom shares are owned by insiders. Comparatively, 0.2% of Baxter International shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

DexCom has a beta of 1.45, meaning that its share price is 45% more volatile than the broader market. Comparatively, Baxter International has a beta of 0.64, meaning that its share price is 36% less volatile than the broader market.

DexCom has a net margin of 19.31% compared to Baxter International's net margin of -9.70%. DexCom's return on equity of 33.33% beat Baxter International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DexCom	19.31%	33.33%	13.19%
Baxter International	-9.70%	16.15%	5.24%

DexCom has higher earnings, but lower revenue than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DexCom	$4.66B	5.81	$836.30M	$2.34	29.97
Baxter International	$11.24B	1.01	-$957M	-$2.13	N/A

DexCom currently has a consensus target price of $84.88, suggesting a potential upside of 21.02%. Baxter International has a consensus target price of $19.73, suggesting a potential downside of 10.49%. Given DexCom's stronger consensus rating and higher possible upside, equities analysts clearly believe DexCom is more favorable than Baxter International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DexCom	1 Sell rating(s)	3 Hold rating(s)	21 Buy rating(s)	2 Strong Buy rating(s)	2.89
Baxter International	3 Sell rating(s)	8 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.92

Summary

DexCom beats Baxter International on 16 of the 17 factors compared between the two stocks.

How does Baxter International compare to ResMed?

ResMed (NYSE:RMD) and Baxter International (NYSE:BAX) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, media sentiment, risk, valuation and institutional ownership.

ResMed has a net margin of 27.44% compared to Baxter International's net margin of -9.70%. ResMed's return on equity of 25.35% beat Baxter International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ResMed	27.44%	25.35%	18.69%
Baxter International	-9.70%	16.15%	5.24%

ResMed has higher earnings, but lower revenue than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than ResMed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ResMed	$5.15B	5.65	$1.40B	$10.37	19.33
Baxter International	$11.24B	1.01	-$957M	-$2.13	N/A

ResMed currently has a consensus target price of $270.82, indicating a potential upside of 35.08%. Baxter International has a consensus target price of $19.73, indicating a potential downside of 10.49%. Given ResMed's stronger consensus rating and higher probable upside, equities analysts clearly believe ResMed is more favorable than Baxter International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ResMed	0 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.67
Baxter International	3 Sell rating(s)	8 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.92

In the previous week, ResMed had 8 more articles in the media than Baxter International. MarketBeat recorded 10 mentions for ResMed and 2 mentions for Baxter International. ResMed's average media sentiment score of 1.38 beat Baxter International's score of 0.59 indicating that ResMed is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ResMed	9 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Baxter International	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

ResMed has a beta of 0.8, suggesting that its share price is 20% less volatile than the broader market. Comparatively, Baxter International has a beta of 0.64, suggesting that its share price is 36% less volatile than the broader market.

ResMed pays an annual dividend of $2.40 per share and has a dividend yield of 1.2%. Baxter International pays an annual dividend of $0.04 per share and has a dividend yield of 0.2%. ResMed pays out 23.1% of its earnings in the form of a dividend. Baxter International pays out -1.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. ResMed has raised its dividend for 13 consecutive years. ResMed is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

55.0% of ResMed shares are held by institutional investors. Comparatively, 90.2% of Baxter International shares are held by institutional investors. 0.7% of ResMed shares are held by company insiders. Comparatively, 0.2% of Baxter International shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

ResMed beats Baxter International on 17 of the 20 factors compared between the two stocks.

Get Baxter International News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BAX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BAX vs. The Competition

Export

Metric	Baxter International	MED PRODUCTS Industry	Medical Sector	NYSE Exchange
Market Cap	$11.38B	$8.46B	$6.83B	$23.30B
Dividend Yield	0.18%	2.48%	2.66%	4.07%
P/E Ratio	-10.35	16.18	25.89	31.64
Price / Sales	1.01	6.67	546.41	20.93
Price / Cash	3.88	18.07	29.09	18.60
Price / Book	1.86	3.37	10.79	4.75
Net Income	-$957M	$226.25M	$3.58B	$1.07B
7 Day Performance	12.25%	2.11%	1.97%	1.36%
1 Month Performance	17.35%	-3.20%	-0.24%	0.70%
1 Year Performance	-27.56%	0.80%	34.40%	25.30%

Baxter International Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BAX Baxter International	1.3924 of 5 stars	$22.04 flat	$19.73 -10.5%	-27.6%	$11.38B	$11.24B	N/A	37,500	Gap Down
AMN AMN Healthcare Services	1.6894 of 5 stars	$30.40 -1.9%	$25.29 -16.8%	+56.1%	$1.20B	$2.73B	N/A	2,664
DVA DaVita	3.9187 of 5 stars	$209.62 +0.8%	$199.17 -5.0%	+53.0%	$13.35B	$13.64B	19.45	78,000	Gap Down
BDX Becton, Dickinson and Company	4.7308 of 5 stars	$140.37 -2.5%	$181.00 +28.9%	-8.6%	$39.67B	$21.84B	35.54	72,000	Positive News Gap Down
DXCM DexCom	4.7539 of 5 stars	$69.07 -4.7%	$84.83 +22.8%	-18.8%	$27.96B	$4.66B	29.52	11,000	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:BAX) was last updated on 6/29/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Baxter International (BAX) Competitors

BAX vs. AMN, DVA, BDX, DXCM, and RMD

How does Baxter International compare to AMN Healthcare Services?

Summary

How does Baxter International compare to DaVita?

Summary

How does Baxter International compare to Becton, Dickinson and Company?

Summary

How does Baxter International compare to DexCom?

Summary

How does Baxter International compare to ResMed?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BAX vs. The Competition

Baxter International Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Baxter International (BAX) Competitors

BAX vs. AMN, DVA, BDX, DXCM, and RMD

How does Baxter International compare to AMN Healthcare Services?

Which has higher valuation & earnings, BAX or AMN?

Is BAX or AMN more profitable?

Which has more risk and volatility, BAX or AMN?

Do institutionals & insiders hold more shares of BAX or AMN?

Do analysts prefer BAX or AMN?

Does the media refer more to BAX or AMN?

Summary

How does Baxter International compare to DaVita?

Do institutionals and insiders believe in DVA or BAX?

Does the media refer more to DVA or BAX?

Which has preferable earnings and valuation, DVA or BAX?

Is DVA or BAX more profitable?

Which has more risk and volatility, DVA or BAX?

Do analysts recommend DVA or BAX?

Summary

How does Baxter International compare to Becton, Dickinson and Company?

Is BAX or BDX more profitable?

Is BAX or BDX a better dividend stock?

Do analysts recommend BAX or BDX?

Which has more volatility & risk, BAX or BDX?

Does the media prefer BAX or BDX?

Do insiders and institutionals have more ownership in BAX or BDX?

Which has better earnings & valuation, BAX or BDX?

Summary

How does Baxter International compare to DexCom?

Does the media favor DXCM or BAX?

Do insiders and institutionals hold more shares of DXCM or BAX?

Which has more volatility and risk, DXCM or BAX?

Is DXCM or BAX more profitable?

Which has stronger valuation & earnings, DXCM or BAX?

Do analysts prefer DXCM or BAX?

Summary

How does Baxter International compare to ResMed?

Is RMD or BAX more profitable?

Which has higher valuation and earnings, RMD or BAX?

Do analysts rate RMD or BAX?

Does the media favor RMD or BAX?

Which has more risk and volatility, RMD or BAX?

Is RMD or BAX a better dividend stock?

Do institutionals & insiders believe in RMD or BAX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BAX vs. The Competition

Baxter International Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools